Paul W. Roche
Volume:
70 - Edition:
1 -
Jan/Feb/Mar -
2002
The paper grip test for screening on intrinsic muscle paralysis in the foot of leprosy patients
Maartje M. L. de Win1;
Wim J. Theuvenet3;
Paul W. Roche4;
Rob A. de Bie5;
Henk van Mameren2
Volume:
69 - Edition:
2 -
Apr/May/Jun -
2001
Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae
Paul W. Roche1;
Kapil Dev Neupane2;
Sarah S. Failbus3;
Arun Kamath4;
Warwick J. Britton5
Volume:
67 - Edition:
3 -
Jul/Aug/Sep -
1999
Risk factors for erythema nodosum leprosum
Rakesh Manandhar1;
Joseph W. LeMaster2;
Paul W. Roche3
Volume:
67 - Edition:
3 -
Jul/Aug/Sep -
1999
Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-I antibodies detected by ELISA and "dipstick" methods
Paul W. Roche1;
Sarah S. Failbus2;
Warwick J. Britton3;
Robert Cole4
Volume:
68 - Edition:
1 -
Jan/Feb/Mar -
2000
Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population
Rakesh Manandhar1;
Joseph W. LeMaster2;
C. Ruth Butlin3;
Patrick J. Brennan4;
Paul W. Roche5
Volume:
68 - Edition:
3 -
Jul/Aug/Sep -
2000
Dapsone drug resistance in the MDT era
Paul W. Roche;
Sarah S. Failbus;
C. Ruth Butlin
Volume:
66 - Edition:
3 -
Jul/Aug/Sep -
1998
Contribution of type 1 reactions to sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisone
Paul W. Roche1;
Wim J. Theuvenet2;
Joseph W. Le Master3;
C. Ruth Butlin4
Volume:
65 - Edition:
4 -
Oct/Nov/Dec -
1997
Risk factors for type 1 reactions in leprosy
Paul W. Roche1;
Joseph Le Master2;
C. Ruth Butlin3
Volume:
65 - Edition:
4 -
Oct/Nov/Dec -
1997
IgM anti-phenolic glycolipid-I antibody measurements f rom skin-smear sites: correlation with venous antibody levels and the bacterial index
C. Ruth Butlin1;
Des Soares2;
Kapil Dev Neupane3;
Sarah S. Failbus4;
Paul W. Roche5
Volume:
61 - Edition:
1 -
Jan/Feb/Mar -
1993
Serological monitoring of the response to chemotherapy in leprosy patients
Paul W. Roche1;
Warwick J. Britton5;
Sarah S. Failbus2;
Kapil Dev Neupane3;
Wim J. Theuvenet4
Volume:
60 - Edition:
1 -
Jan/Feb/Mar -
1992
Cellular immune responses to mycobacterial heat shock proteins in nepali leprosy patients and controls
Paul W. Roche1;
Wim J. Theuvenet2;
Warwick J. Britton3
Volume:
60 - Edition:
2 -
Apr/May/Jun -
1992
Antibody responses to the 18-kDa Protein of Mycobacterium leprae in leprosy and tuberculosis patients
Paul W. Roche1;
Ross L. Prestidge2;
James D. Watson2;
Warwick J. Britton3
Volume:
58 - Edition:
3 -
Jul/Aug/Sep -
1990
Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses
Paul W. Roche1;
Warwick J. Britton2;
Sarah S. Failbus3;
David Williams4;
Hira M. Pradhan5;
Wim J. Theuvenet6
Volume:
58 - Edition:
2 -
Apr/May/Jun -
1990
Heterogeneity ot serological responses in paucibacillary leprosy - differential responses to protein and carbohydrate antigens and correlation with clinical parameters
Paul W. Roche1;
Warwick J. Britton2;
Sarah S. Failbus3;
Heike Ludwig5;
Wim J. Theuvenet4;
Ram B. Adiga6